Bioequivalence of Oxazepam 50 mg Orodispersible Tablets Versus Seresta® 50 mg Tablets in Healthy Subjects.
Phase 1
Active, not recruiting
- Conditions
- o medical condition is being investigated. This is a comparative bioavailability study.MedDRA version: 20.0Level: PTClassification code: 10002855Term: Anxiety Class: 100000004873MedDRA version: 20.0Level: PTClassification code: 10012225Term: Delirium tremens Class: 100000004873Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Registration Number
- CTIS2022-501135-16-00
- Lead Sponsor
- aboratorios Lesvi S.L.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method